Pharma sector's Q4 results show moderate gains amid Covid-19 pandemic

The ongoing April-June quarter should see strong growth due to low base of last year

What will be the impact of the second wave and the pandemic in general on Indian pharmaceutical companies? It should lead to a rise in volumes, given that Indian companies are the world’s biggest bulk drug exporters.

India exports roughly 20 per cent of the world’s generic drugs. However, at another level, Indian companies are still struggling with some supply chain issues. Wuhan, the epicentre of the Covid-19 outbreak, was also the centre of the world’s supply of API (active pharma ingredients). Replacing that source has been difficult.

The current April-June quarter will be difficult to assess due to the lockdown last